WTO TRIPS Agreement spurs innovation in the Indian biopharmaceutical industry
The upgrading of India’s IP laws as a result of its WTO commitments has confounded sceptics by encouraging its generics companies to move towards innovation.
The upgrading of India’s IP laws as a result of its WTO commitments has confounded sceptics by encouraging its generics companies to move towards innovation.